Alexandra Nehring

Alexandra Nehring

Auto-generated profile, based on publicly available information

Alexandra Nehring

Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University Bochum (IPA), Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Toxicology Letters
Verified
Journal Article
Closed access
ANAlexandra Nehring
Alexandra Nehring
DBDaniel Bury
Daniel Bury
BRBenedikt Ringbeck
Benedikt Ringbeck
HKHans-Willi Kling
Hans-Willi Kling
RORainer Otter
Rainer Otter
Holger KochHolger Koch
Holger Koch

1 August 2019 in Journal of Chromatography B
Verified
Journal Article
Closed access
ANAlexandra Nehring
Alexandra Nehring
DBDaniel Bury
Daniel Bury
HKHans-Willi Kling
Hans-Willi Kling
TWTobias Weiss
Tobias Weiss
TBThomas Bruening
Thomas Bruening
Holger KochHolger Koch
Holger Koch

1 June 2021 in Toxicology Letters
Verified
Journal Article
Closed access
BRBenedikt Ringbeck
Benedikt Ringbeck
DBDaniel Bury
Daniel Bury
AGAlexandra Gotthardt
Alexandra Gotthardt
HHHeiko Hayen
Heiko Hayen
RORainer Otter
Rainer Otter
Holger KochHolger Koch
Holger Koch

19 February 2021 in EXCLI Journal
Verified
Journal Article
Open access
AGAlexandra Gotthardt
Alexandra Gotthardt
DBDaniel Bury
Daniel Bury
HKHans-Willi Kling
Hans-Willi Kling
RORainer Otter
Rainer Otter
TWTobias Weiss
Tobias Weiss
Holger KochHolger Koch
Holger Koch
Diisononyl adipate (DINA) is a plasticizer used in PVC products as an alternative for restricted phthalate plasticizers. With this study, we provide first data on human DINA metabolism and excretion. We postulated mono(hydroxy-isononyl) adipate (OH-MINA), mono(oxo-isononyl) adipate (oxo-MINA), and mono(carboxy-isooctyl) adipate (cx-MIOA) as specific DINA metabolites based on the known human metabolism of structurally similar adipates and phthalates. Urinary excretion was quantitatively investigated after a single oral dose (113 to 145 µg/kg body weight) to three healthy volunteers using a newly developed online-SPE-LC-MS/MS method with isotope dilution and LOQs between 0.3 – 0.6 µg/L. OH-MINA turned out to be the major of the three metabolites with consistent urinary excretion fractions (FUEs) of 0.020-0.023 % among all volunteers. Oxo-MINA and cx-MIOA were excreted with lower shares (mean: 0.003 % and 0.009 %, respectively). For all three metabolites, urinary concentrations peaked quickly between 1.4 and 2.3 h post dose with maximum concentrations of 23.1 (OH-MINA), 2.87 (oxo-MINA) and 9.83 µg/L (cx-MIOA). Thus, FUEs and urinary concentrations were rather low for these specific metabolites, with the major share of the dose presumably being excreted as non-specific metabolites such as adipic acid. In a pilot population (n=35) of German adults without known DINA exposure, we could not detect any of the three metabolites, contrary to the dosage study, indicating to population exposures lower than 50 µg/kg body weight/day. The new HBM method in conjunction with the new FUEs can be used for objective DINA exposure and risk assessment especially in populations with potentially higher DINA exposures.